Strata Critical Medical, Inc.
SRTAHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Strata Critical Medical, Inc. focuses on Medical Care Facilities services and products. Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. The $445.6M market capitalization puts SRTA squarely in small-cap range for its industry. It operates in two segments, Logistics and Clinical.
Market Cap
$445.6M
Beta
2.22
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.19
EPS (Fwd)
—
ROE
-6.3%
ROA
-1.9%
Cash
$58.8M
Total Debt
$4.5M
Free CF
-$24.0M
52W Change
20.6%
Annual Financials
Cash vs Debt
With $58.8M in cash and $4.5M in debt, SRTA maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$24.0M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -6.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $146.1M (2022) to $197.1M (2025), reflecting a 35% increase over the period.
A beta of 2.22 means SRTA is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. With cash comfortably exceeding debt, SRTA has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Strata Critical Medical, Inc. and its sector.